U.S. Banks Stock News

Why insider buying has put NextDecade back on investor watchlists NextDecade (NEXT) is back in focus after a director bought a large block of shares and a new major holder disclosed a substantial passive stake, prompting fresh debate about what the current valuation implies. See our latest analysis for NextDecade. Those insider moves arrived as the share price has been strong in recent months, with a 39.7% 1 month share price return and 45.9% year to date share price return, while the 5 year...

In recent days, First Financial Bancorp. has attracted renewed attention after eight brokerages assigned the bank a consensus “Moderate Buy” rating, citing strong loan growth, improved net interest margins, and disciplined expense management across its Midwest footprint. This broad-based analyst support highlights how operational efficiency efforts and loan growth trends are increasingly shaping perceptions of the bank’s longer-term earnings profile and risk balance. With this fresh analyst...

Graham Holdings recently reported mixed quarterly results, with revenue growth in education, healthcare, and manufacturing offset by weaker performance in television broadcasting and automotive, and completed the purchase of Covenant Home Health to build out its residential home health offerings. Kaplan’s new partnership with South Carolina State University to provide free exam preparation highlights how Graham Holdings is using education services and healthcare expansion to diversify beyond...

Tarsus Pharmaceuticals has already dosed the first participant in its Phase 2 Calliope trial of TP-05, an oral lotilaner-based therapy being tested in about 700 at-risk adults across U.S. Lyme-endemic regions, where no FDA-approved drug prophylaxis currently exists. This move extends Tarsus beyond eye-care into infectious disease prevention, targeting a large U.S. population considered at moderate to high risk for Lyme disease. We’ll now examine how TP-05’s Phase 2 progress, as a potential...

Earnings pop puts Universal Display’s latest move in focus Universal Display (OLED) recently reported financial results that featured strong revenue growth and a small earnings miss, yet the stock climbed nearly 16% as investors reacted to the company’s commentary and capital allocation plans. See our latest analysis for Universal Display. That earnings reaction sits against a tougher backdrop, with a 90 day share price return showing a 29.02% decline and a 1 year total shareholder return...

Cboe Global Markets plans to introduce 24-hour, 5-days-per-week trading for U.S. equities on its EDGX exchange, pending regulatory review. The move would extend U.S. stock trading to an around-the-clock schedule on weekdays, aligning more closely with global trading hours. The initiative is aimed at giving investors continuous access to U.S. equities and could influence liquidity patterns and competition across trading venues. Cboe Global Markets (BATS:CBOE) is pursuing this expanded...

In March 2026, Fidelity National Financial, Inc. appointed Jeffrey Heighton as President of Enterprise Solutions – Agency to work with title agents on growth, financial performance, and technology-driven operational scale. This hire expands FNF’s consultative model for its agency network, deepening support around revenue strategy, expense management, and back-office optimization. Next, we’ll examine how AI-driven downgrades tied to weakening cash flow and profitability pressures may...

Wolfe Research’s new coverage of BeOne Medicines (NasdaqGS:ONC), paired with recent FDA orphan drug designation for its hepatocellular carcinoma treatment, has pushed this oncology group back into focus for biotech investors. See our latest analysis for BeOne Medicines. After a strong run, with a 7 day share price return of 9.4% and a 1 year total shareholder return of 40.92%, recent coverage initiations and the FDA orphan drug designation appear to have reinforced interest following earlier...

Recent slowdown in growth and returns puts Simpson Manufacturing under the spotlight Simpson Manufacturing (SSD) is back on investors’ radar after fresh analysis flagged a clear slowdown in annualized revenue growth, a decline in earnings per share, and a drop in return on invested capital, all pointing to cooler momentum. See our latest analysis for Simpson Manufacturing. At a share price of $166.30, Simpson Manufacturing has seen a 10.6% 1 month share price decline and a 2.3% 3 month share...

Over the last 7 days, the United States market has risen by 3.5%, and in the last year, it has climbed an impressive 31%, with earnings expected to grow by 16% per annum over the next few years. In this dynamic environment, identifying high growth tech stocks that align with these positive market trends can be key to achieving potential portfolio gains.

Over the last 7 days, the United States market has risen by 3.5%, contributing to a remarkable 31% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, identifying stocks that are potentially undervalued can offer investors opportunities to capitalize on price discrepancies relative to their intrinsic value.

In the past week, the United States market has experienced a 3.5% increase and boasts a remarkable 31% rise over the last year, with earnings projected to grow by 16% annually. In such an environment, stocks with high insider ownership can be particularly appealing as they often indicate confidence from those closest to the company's operations and potential for promising growth.

The United States market has shown robust growth, rising 3.5% over the last week and 31% over the past year, with earnings expected to increase by 16% annually in the coming years. In such a thriving market, identifying stocks with strong financials becomes crucial for investors seeking both affordability and growth potential. Although often considered a term from bygone eras, penny stocks continue to offer intriguing opportunities within smaller or newer companies that might surprise...

The United States market has shown impressive strength, rising 3.5% over the last week and climbing 31% over the past year, with earnings projected to grow by 16% annually. In such a robust environment, identifying lesser-known stocks with strong fundamentals and growth potential can offer intriguing opportunities for investors seeking to diversify their portfolios.

The market in the United States has shown a notable uptick, rising 3.5% over the last week and achieving a 31% increase over the past year, with earnings projected to grow by 16% annually. In such an environment, dividend stocks that offer consistent payouts and potential for growth can be appealing options for investors seeking to benefit from both income and capital appreciation.

In recent days, GeneDx Holdings faced weakening sentiment as bearish technical signals and mixed analyst views coincided with institutional investors reducing their exposure to the company. This divergence between institutional outflows and lingering retail optimism highlights a growing disconnect in how different investor groups interpret GeneDx’s prospects. We’ll now examine how institutional caution and shifting sentiment could influence GeneDx’s existing investment narrative built around...

Pursuit Attractions and Hospitality recently reported Q4 results that came in slightly below consensus, while confirming 2025 as a defining year with record revenue, record adjusted EBITDA, an ongoing portfolio transformation, and active share repurchases. The company also laid out long-term ambitions through 2030, targeting revenue above US$845 million and adjusted EBITDA over US$265 million, underpinned by disciplined capital allocation, international expansion, and a focused investment...

Rush Enterprises recently appointed long-time executive Jody Pollard as Chief Operating Officer, replacing Jason Wilder, who left the company after nearly two decades in leadership roles across its dealership network. Pollard’s promotion from Senior Vice President roles in operations and truck/aftermarket sales, alongside close collaboration with CEO Rusty Rush and former COO Michael McRoberts, underscores the company’s emphasis on continuity in operational leadership. We’ll now examine how...

In its recent earnings call, JOYY highlighted accelerating ad-tech momentum, improving non-GAAP profitability, strong cash generation, and a sizeable net cash balance, while announcing a shift to three reporting segments starting Q1 2026. A key highlight was the rapid expansion of BIGO Ads’ third-party Audience Network, which is emerging as a central growth engine within JOYY’s evolving business mix. Next, we’ll examine how JOYY’s move to three reporting segments and spotlight on BIGO Ads...

LTC Properties Inc. recently declared past monthly cash dividends of US$0.19 per common share for each month of the second quarter of 2026, with record dates on April 22, May 21, and June 22, and corresponding payment dates on April 30, May 29, and June 30. This steady monthly payout underscores how LTC’s healthcare-focused REIT model aims to support dependable income for investors alongside its expanding senior housing portfolio. We’ll now examine how LTC’s recently affirmed monthly...

Plains All American Pipeline recently agreed to sell its Canadian natural gas liquids assets and lifted its quarterly dividend by 10% to US$0.4175 per unit, aiming to increase the share of fee-based income to about 85% and improve cash flow predictability. While the sale is intended to lower leverage and sharpen the focus on steadier earnings, the dividend now sits on a payout ratio slightly above 100%, raising fresh questions about how secure that higher income stream may be. Next, we’ll...

Clarivate (CLVT) put artificial intelligence at the center of its story with the Clarivate AI50 report, a new benchmark spotlighting organizations leading high impact AI inventions across key regions and sectors worldwide. See our latest analysis for Clarivate. Despite the AI50 launch drawing fresh attention, Clarivate’s 7 day share price return of 4.55% sits against a 90 day share price return decline of 25.37% and a 5 year total shareholder return decline of 90.25%, so recent momentum is...

Cognyte Software reported fourth-quarter 2026 results showing revenue of US$106.24 million and net income of US$3.76 million, alongside full-year revenue of US$400.04 million and a sharply reduced annual net loss, while also updating on its share buyback and filing an ESOP-related shelf registration for 3,300,000 ordinary shares worth US$26.00 million. The company also announced a US$5 million tactical SIGINT contract win with a major U.S. state law enforcement agency and issued guidance...

Recent share performance and what it might signal CarGurus (CARG) has been trading with mixed momentum, with a 1 day return of about a 0.7% decline, a 7 day move of roughly a 5.5% decline, and a month change near a 1% decline. Over the past 3 months the stock shows about a 13% decline, while year to date it is down roughly 11%. Even so, the 1 year total return stands near 29%, and around 91% over 3 years. See our latest analysis for CarGurus. With the share price at US$33.33 and recent share...